NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,065 | -18.3% | 337 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $1,304 | +39.8% | 337 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $933 | +53.7% | 337 | 0.0% | 0.00% | – |
| Q4 2022 | $607 | -39.3% | 337 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | -99.9% | 337 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $907,000 | +45250.0% | 337 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,000 | 0.0% | 337 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,000 | – | 337 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $47,848,000 | 7.75% |
| AMAZON COM INC | 1,457,055 | $14,716,000 | 3.85% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $15,150,000 | 3.76% |
| Affinity Asset Advisors, LLC | 900,000 | $9,090,000 | 3.25% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $20,200,000 | 1.32% |
| Perceptive Advisors | 17,822,302 | $180,004,000 | 1.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $8,080,000 | 0.55% |
| HILLMAN CO | 200,000 | $2,020,000 | 0.52% |
| RA Capital Management | 2,471,430 | $24,961,000 | 0.40% |
| Nantahala Capital Management | 1,190,810 | $12,027,000 | 0.34% |